EUVIMEDEUVIMED entdecken
Crossref

Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study

Hideharu Okanobu, Tomohiko Kohno, Kazuki Boda, Hidenori Ochi, Yoshinari Furukawa

Digestion · 2023

DOI: 10.1159/000528690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestion, 2023. Verfasst von Hideharu Okanobu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan. Hauptthemen laut MEDLINE: Hernia, Hiatal, Esophagitis, Peptic Ulcer, Esophagitis, Peptic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to investigate the clinical course of patients with healed mild erosive esophagitis and clarify the predictive factors for continuous treatment.

Method

Fifty-one patients with mild erosive esophagitis who confirmed mucosal healing by endoscopy after initial treatment with vonoprazan (VPZ) were enrolled. The patients continued subsequent treatment of their choice: maintenance therapy with VPZ 10 mg (n = 15), on-demand therapy with VPZ 20 mg (n = 19), or no medication (n = 17). Each patient was prospectively followed up for over 2 years, and the treatment was switched to other options appropriately according to their symptoms.

Results

During the mean follow-up period of 3.1 years (range: 2.0–3.9 years), 2 patients who chose maintenance therapy switched to on-demand therapy. One patient who chose on-demand therapy switched to maintenance therapy, while 3 patients switched to no medication. Recurrence of symptoms occurred in 9 patients who chose no medication. They were administered maintenance therapy and five of them were subsequently switched to on-demand therapy. Ultimately, the proportion of patients receiving each treatment was 35.3% (18/51) for maintenance therapy, 43.1% (22/51) for on-demand therapy, and 21.6% (11/51) for no medication. A predictive factor for the need for continuous treatment was the presence of esophageal hiatal hernia (odds ratio: 6.03, 95% confidence interval: 1.43–25.3, p = 0.014).

Conclusion

Among patients with healed mild erosive esophagitis, 78.4% required continuous treatment with VPZ, while 21.6% remained symptom free with no medication. On-demand therapy was the most common treatment, and continuous treatment may be recommended for patients with esophageal hiatal hernia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hernia, HiatalEsophagitisPeptic UlcerEsophagitis, PepticHumansFollow-Up StudiesProton Pump InhibitorsProspective StudiesEndoscopy, GastrointestinalDisease ProgressionPyrrolesSulfonamides

Stichwörter der Autor:innen

Clinical courseGERDMild erosive esophagitisPredictive factorVonoprazan

Substanzen

Proton Pump Inhibitors1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanaminePyrrolesSulfonamides

Autor:innen und Institutionen

  • Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Department of Medical Checkup Center, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.

Zitieren

APA

Okanobu, H., Kohno, T., Boda, K., Ochi, H., & Furukawa, Y. (2023). Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study. Digestion. https://doi.org/10.1159/000528690

Vancouver

Okanobu H, Kohno T, Boda K, Ochi H, Furukawa Y. Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study. Digestion. 2023. doi:10.1159/000528690

BibTeX
@article{Okanobu2023,
  author = {Okanobu, Hideharu and Kohno, Tomohiko and Boda, Kazuki and Ochi, Hidenori and Furukawa, Yoshinari},
  title = {Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study},
  journal = {Digestion},
  year = {2023},
  doi = {10.1159/000528690}
}
Kostenlos starten →